ESC Premium Access

Cardiovascular Disease Prevention and Treatment: What Drives Change?

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Public Health and Health Economics
Session type: Abstract Sessions
Date: 31 August 2020
Time: 08:30 - 08:30

Session

5 presentations in this session

A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom

Speaker: Doctor E. Sidelnkov (Zug, CH)
Thumbnail

Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009-2017

Speaker: Ms I. Thalmann (Oxford, GB)
Thumbnail

Management of conflicts of interests of ESC guideline authors

Speaker: Professor H. Seggewiss (Wurzburg, DE)
Thumbnail

Burnout in residency: are cardiology residents more affected?

Speaker: Mr A. Sigal (Buenos Aires, AR)
Thumbnail

The assessment of the accuracy and credibility of cardiovascular health information on social media platforms

Speaker: Doctor A. Ragab (Rotterdam, NL)
Thumbnail

5 speakers from this session

Doctor Eduard Sidelnkov

Amgen Europe GmbH, Zug (Switzerland)
0 follower

Ms Inna Thalmann

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
0 follower

Professor Hubert Seggewiss

Comprehensive Heart Failure Center (CHFC), Wurzburg (Germany)
3 presentations
0 follower

Mr Alan Rodrigo Sigal

Instituto Cardiovascular De Buenos Aires, Buenos Aires (Argentina)
0 follower

Doctor Ahmed Adel Ragab

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
0 follower

This platform is supported by

logo Novo Nordisk